Sanofi will cut an undisclosed number of jobs as it revamps its U.S. vaccines commercial operations, as well as 99 employees from its Belgian sites—moves that are part of a full pipeline reprioritization.
https://www.biospace.com/article/sanofi-layoffs-car-t-warnings-and-a-new-glp-1-player/